Patients with cancer-associated thrombosis (CAT) are at high risk of recurrent venous
thromboembolism (VTE) and major bleeding complications. Risks vary significantly between …

Background Data on anticoagulant treatment for upper extremity deep vein thrombosis
(UEDVT) are largely derived from studies on usual site venous thromboembolism (VTE) …

Background Catheter-related thrombosis (CRT) of the upper extremities is a frequent
complication among cancer patients that carry a central venous catheter (CVC) and may …

Background Data on complications following upper extremity vein thrombosis (UEVT) are
limited and heterogeneous. Methods The aim of the study was to evaluate the pooled …

One in two people will develop cancer at some point in their lives 1 and venous
thromboembolism (VTE) will complicate the clinical journey of one in 20 cancer patients. 2 …

Direct oral anticoagulants (DOACs) are commonly used oral factor Xa inhibitors in recent
years. However, in some special clinical situations, the appropriate use of these …

Upper extremity deep vein thrombosis (UEDVT) may occur without inciting factor or may be
secondary to malignancy, surgery, trauma, central venous catheter or related to thoracic …

Rationale: Venous thromboembolism is a feared frequent complication of cancer with a 2-
way relationship. Low molecular weight heparin is the mainstay of treatment. The use of …

Objectives: We aimed to investigate the clinical features of upper extremity deep vein
thrombosis (UEDVT). Methods: We retrospectively reviewed the background, thrombus site …

BACKGROUND: Data on anticoagulant treatment for upper extremity deep vein thrombosis
(UEDVT) are largely derived from studies on usual site venous thromboembolism (VTE) …